- Home
- QQQX vs INVA Comparison
QQQX vs INVA Comparison
Compare QQQX & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QQQX | INVA |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | QQQX | INVA |
|---|---|---|
| Price | $30.91 | $21.04 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.80 |
| AVG Volume (30 Days) | 74.8K | ★ 572.9K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 7.03% | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $217,217,000.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | N/A | $12.65 |
| P/E Ratio | ★ N/A | $16.89 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $25.35 | $16.52 |
| 52 Week High | $31.87 | $25.15 |
Technical Indicators
Market Signals| Indicator | QQQX | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 57.06 | 52.07 |
| Support Level | $29.54 | $20.44 |
| Resistance Level | $30.87 | $21.81 |
| Average True Range (ATR) | 0.37 | 0.41 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 88.19 | 70.75 |
Price Performance
Historical ComparisonAbout QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets (as defined below) in a diversified equity portfolio made up of securities comprising the S&P 500 Index (or securities that have economic characteristics that are similar to those securities comprising the S&P 500 Index) that seeks to substantially replicate price movements of the S&P 500 Index and is designed to support the Fund's option strategy.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.